Growth Metrics

Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2016 - 2026)

Ironwood Pharmaceuticals' Total Current Liabilities history spans 16 years, with the latest figure at $242.2 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 523.53% to $242.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $242.2 million, a 523.53% increase, with the full-year FY2025 number at $242.2 million, up 523.53% from a year prior.
  • Total Current Liabilities hit $242.2 million in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from $242.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for IRWD hit a ceiling of $305.4 million in Q2 2023 and a floor of $23.3 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $136.3 million across 5 years, with a median of $140.0 million in 2021.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 1210.8% in 2023 and later tumbled 85.93% in 2024.
  • Tracing IRWD's Total Current Liabilities over 5 years: stood at $161.7 million in 2021, then plummeted by 84.21% to $25.5 million in 2022, then soared by 981.69% to $276.1 million in 2023, then tumbled by 85.93% to $38.8 million in 2024, then skyrocketed by 523.53% to $242.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for IRWD at $242.2 million in Q4 2025, $242.5 million in Q3 2025, and $232.5 million in Q2 2025.